Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 9
2004 13
2005 14
2006 18
2007 14
2008 19
2009 16
2010 29
2011 26
2012 37
2013 30
2014 32
2015 44
2016 33
2017 35
2018 43
2019 33
2020 43
2021 57
2022 52
2023 58
2024 48

Text availability

Article attribute

Article type

Publication date

Search Results

615 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial.
Kaseb AO, Hasanov E, Cao HST, Xiao L, Vauthey JN, Lee SS, Yavuz BG, Mohamed YI, Qayyum A, Jindal S, Duan F, Basu S, Yadav SS, Nicholas C, Sun JJ, Singh Raghav KP, Rashid A, Carter K, Chun YS, Tzeng CD, Sakamuri D, Xu L, Sun R, Cristini V, Beretta L, Yao JC, Wolff RA, Allison JP, Sharma P. Kaseb AO, et al. Among authors: lee ss. Lancet Gastroenterol Hepatol. 2022 Mar;7(3):208-218. doi: 10.1016/S2468-1253(21)00427-1. Epub 2022 Jan 20. Lancet Gastroenterol Hepatol. 2022. PMID: 35065057 Free PMC article. Clinical Trial.
Understanding nucleic acid sensing and its therapeutic applications.
Kong LZ, Kim SM, Wang C, Lee SY, Oh SC, Lee S, Jo S, Kim TD. Kong LZ, et al. Among authors: lee s. Exp Mol Med. 2023 Nov;55(11):2320-2331. doi: 10.1038/s12276-023-01118-6. Epub 2023 Nov 9. Exp Mol Med. 2023. PMID: 37945923 Free PMC article. Review.
Convergent MAPK pathway alterations mediate acquired resistance to FGFR inhibitors in FGFR2 fusion-positive cholangiocarcinoma.
DiPeri TP, Zhao M, Evans KW, Varadarajan K, Moss T, Scott S, Kahle MP, Byrnes CC, Chen H, Lee SS, Halim AB, Hirai H, Wacheck V, Kwong LN, Rodon J, Javle M, Meric-Bernstam F. DiPeri TP, et al. Among authors: lee ss. J Hepatol. 2024 Feb;80(2):322-334. doi: 10.1016/j.jhep.2023.10.041. Epub 2023 Nov 14. J Hepatol. 2024. PMID: 37972659
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.
Gok Yavuz B, Datar S, Chamseddine S, Mohamed YI, LaPelusa M, Lee SS, Hu ZI, Koay EJ, Tran Cao HS, Jalal PK, Daniel-MacDougall C, Hassan M, Duda DG, Amin HM, Kaseb AO. Gok Yavuz B, et al. Among authors: lee ss. Cancers (Basel). 2023 Oct 7;15(19):4875. doi: 10.3390/cancers15194875. Cancers (Basel). 2023. PMID: 37835569 Free PMC article. Review.
Immunomodulation in hepatocellular cancer.
Lee S, Loecher M, Iyer R. Lee S, et al. J Gastrointest Oncol. 2018 Feb;9(1):208-219. doi: 10.21037/jgo.2017.06.08. J Gastrointest Oncol. 2018. PMID: 29564186 Free PMC article. Review.
Systemic therapy of liver cancer.
Demir T, Lee SS, Kaseb AO. Demir T, et al. Among authors: lee ss. Adv Cancer Res. 2021;149:257-294. doi: 10.1016/bs.acr.2020.12.001. Epub 2021 Jan 29. Adv Cancer Res. 2021. PMID: 33579425 Review.
Quo Vadis Oncological Hyperthermia (2020)?
Lee SY, Fiorentini G, Szasz AM, Szigeti G, Szasz A, Minnaar CA. Lee SY, et al. Front Oncol. 2020 Sep 4;10:1690. doi: 10.3389/fonc.2020.01690. eCollection 2020. Front Oncol. 2020. PMID: 33014841 Free PMC article. Review.
615 results